Showing results (151-160 of 343) with videos related to
Sort By:
Pageof 35
Behavioural Brain Research|June 30, 2020
Circadian disruption impairs fear extinction and memory of conditioned safety in miceJacob W Clark, Daniel Hoyer, Sean W Cain, et al.Journal of Ophthalmology|December 9, 2021
Evaluation of a Novel Zonular Tension Restoring Accommodating Silicone IOL Design: Pilocarpine and Cyclopentolate-Induced Effect 20 Months after ImplantationNino Hirnschall, Raoul Paolo D Henson, Jay Marianito S Vicencio, et al.Antiviral Therapy|December 3, 2008
Determinants of virological failure after successful viral load suppression in first-line highly active antiretroviral therapyAnna M Geretti, Colette Smith, Annette Haberl, et al.Plos Computational Biology|October 25, 2011
A peptide filtering relation quantifies MHC class I peptide optimizationNeil Dalchau, Andrew Phillips, Leonard D Goldstein, et al.Plos One|October 19, 2022
Effectiveness of interventions aimed at reducing HIV acquisition and transmission among gay and bisexual men who have sex with men (GBMSM) in high income settings: A systematic reviewJaney Sewell, Ibidun Fakoya, Fiona C Lampe, et al.Mabs|March 9, 2026
NAStructuralDB : structural database to facilitate computational studies of molecular modeling and recognition of proteins with special focus on antibody-antigen interactionsDawid Chomicz, Paweł Dudzic, Sonia Wrobel, et al.Malawi Medical Journal : the Journal of Medical Association of Malawi|August 30, 2021
A cross-sectional study on factors associated with health seeking behaviour of Malawians aged 15+ years in 2016Wingston Ng'ambi, Tara Mangal, Andrew Phillips, et al.The Journal of Antimicrobial Chemotherapy|January 11, 2007
Prevalence and predictors of antiretroviral drug resistance in newly diagnosed HIV-1 infectionClare L Booth, Ana M Garcia-Diaz, Michael S Youle, et al.Antiviral Therapy|May 9, 2013
Second-line protease inhibitor-based antiretroviral therapy after non-nucleoside reverse transcriptase inhibitor failure: the effect of a nucleoside backboneLaura Waters, Loveleen Bansi, David Asboe, et al.AIDS (London, England)|January 29, 2014
Predicted levels of HIV drug resistance: potential impact of expanding diagnosis, retention, and eligibility criteria for antiretroviral therapy initiationValentina Cambiano, Silvia Bertagnolio, Michael R Jordan, et al.Pageof 35